About us

Pelago Bioscience was founded in 2013 with the aim to develop the patented Cellular Thermal Shift Assay (CETSA®) for maximum utility and customer value in drug discovery and diagnostics. Today, we deliver in situ target engagement studies to accelerate preclinical and clinical drug discovery and development to a world-wide customer base. Using CETSA® data and applications, our customers are able to make better and more informed decisions at earlier stages in their projects. Our scientific team are the experts in both targeted CETSA® using antibodies for the detection and proteome-wide mass spectrometry-based CETSA® applications, find out more on the Pelago services page

The Pelago Bioscience Team

Veerle Paternoster

Senior Research Scientist

Tove Boström

Senior Research Scientist

Stina Lundgren

Head of Commercial Operations

Sean Tyacke


Sarah Sandoz

Senior Research Scientist

Rikard Alm

Senior Research Scientist

Renato Alves

Senior Research Scientist

Neda Bigdeli

Laboratory Manager

Michael Dabrowski


Marie Karlsson

Research Scientist

Johan Karlsson

Finance Manager

Joakim Hellner

Senior Research Scientist